Molecular Therapy — Nucleic Acids · 2025 · 10 citations · 45 references
Life SciencesImmunologyMolecular BiologyEpigeneticsEpigenomicsImmunotherapyEpigenetic AlterationsEpigenetic ReprogrammingEpigenome EditingEpigenomic ProfilingImmune Checkpoint RegulationT Cell ExhaustionCar T-cell ExhaustionFunctional AssaysOff-target Epigenetic EffectsT Cell Checkpoint InhibitionT Cell EpigeneticsTargeted Epigenetic SilencingTargeted Gene SilencingTherapeutic Epigenome Editing
, both in primary human T cells and in prostate-cancer-specific CAR T cells. Epigenetically modified CAR T cells are indistinguishable from parental cells across a range of functional assays. Although the model does not fully mimic T cell exhaustion, limiting functional assessment, gene silencing remains durable across multiple divisions and repeated CAR stimulations. Furthermore, transcriptomic analysis revealed minimal off-target effects not directly attributable to the effectors used. We demonstrate that targeted epigenome editing is effective and safe for multiplexed gene inhibition and holds potential in engineering CAR T cells with enhanced and customizable features.
45
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin, Carrie Davis, Felix Schlesinger et al. · Bioinformatics · 2012 · 56.2K citations · Full text
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner et al. · New England Journal of Medicine · 2018 · 5.6K citations · Full text
Medicine, Hematology, Oncology +17
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.4K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17